224 related articles for article (PubMed ID: 27411844)
1. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of lysine methyltransferase SETD8 in human diseases.
Milite C; Feoli A; Viviano M; Rescigno D; Cianciulli A; Balzano AL; Mai A; Castellano S; Sbardella G
Clin Epigenetics; 2016; 8():102. PubMed ID: 27688818
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
Ma A; Yu W; Li F; Bleich RM; Herold JM; Butler KV; Norris JL; Korboukh V; Tripathy A; Janzen WP; Arrowsmith CH; Frye SV; Vedadi M; Brown PJ; Jin J
J Med Chem; 2014 Aug; 57(15):6822-33. PubMed ID: 25032507
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of SETD8 inhibitors.
Ma A; Yu W; Xiong Y; Butler KV; Brown PJ; Jin J
Medchemcomm; 2014 Dec; 5(12):1892-1898. PubMed ID: 25554733
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors of SETD8 with cellular activity.
Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase.
Butler KV; Ma A; Yu W; Li F; Tempel W; Babault N; Pittella-Silva F; Shao J; Wang J; Luo M; Vedadi M; Brown PJ; Arrowsmith CH; Jin J
J Med Chem; 2016 Nov; 59(21):9881-9889. PubMed ID: 27804297
[TBL] [Abstract][Full Text] [Related]
7. Roles for the methyltransferase SETD8 in DNA damage repair.
Xu L; Zhang L; Sun J; Hu X; Kalvakolanu DV; Ren H; Guo B
Clin Epigenetics; 2022 Mar; 14(1):34. PubMed ID: 35246238
[TBL] [Abstract][Full Text] [Related]
8. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
[TBL] [Abstract][Full Text] [Related]
9. USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation.
Hernández-Reyes Y; Paz-Cabrera MC; Freire R; Smits VAJ
Cells; 2022 Aug; 11(16):. PubMed ID: 36010569
[TBL] [Abstract][Full Text] [Related]
10. The Use of Nucleosome Substrates Improves Binding of SAM Analogs to SETD8.
Strelow JM; Xiao M; Cavitt RN; Fite NC; Margolis BJ; Park KJ
J Biomol Screen; 2016 Sep; 21(8):786-94. PubMed ID: 27369108
[TBL] [Abstract][Full Text] [Related]
11. A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausing.
Kapoor-Vazirani P; Vertino PM
J Biol Chem; 2014 Mar; 289(11):7425-37. PubMed ID: 24459145
[TBL] [Abstract][Full Text] [Related]
12. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
[TBL] [Abstract][Full Text] [Related]
13. Histone lysine methyltransferase Pr-set7/SETD8 promotes neural stem cell reactivation.
Huang J; Gujar MR; Deng Q; Y Chia S; Li S; Tan P; Sung WK; Wang H
EMBO Rep; 2021 Apr; 22(4):e50994. PubMed ID: 33565211
[TBL] [Abstract][Full Text] [Related]
14. Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.
Herviou L; Ovejero S; Izard F; Karmous-Gadacha O; Gourzones C; Bellanger C; De Smedt E; Ma A; Vincent L; Cartron G; Jin J; De Bruyne E; Grimaud C; Julien E; Moreaux J
Clin Epigenetics; 2021 Sep; 13(1):174. PubMed ID: 34530900
[TBL] [Abstract][Full Text] [Related]
15. [The biological functions of lysine methyltransferase PR-SET7].
Liang XQ; Du YP; Wang DL; Yang Y
Yi Chuan; 2013 Mar; 35(3):241-54. PubMed ID: 23575530
[TBL] [Abstract][Full Text] [Related]
16. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
[TBL] [Abstract][Full Text] [Related]
17. Methylation of histone H4 lysine 20 by PR-Set7 ensures the integrity of late replicating sequence domains in Drosophila.
Li Y; Armstrong RL; Duronio RJ; MacAlpine DM
Nucleic Acids Res; 2016 Sep; 44(15):7204-18. PubMed ID: 27131378
[TBL] [Abstract][Full Text] [Related]
18. The histone methyltransferase SET8 is required for S-phase progression.
Jørgensen S; Elvers I; Trelle MB; Menzel T; Eskildsen M; Jensen ON; Helleday T; Helin K; Sørensen CS
J Cell Biol; 2007 Dec; 179(7):1337-45. PubMed ID: 18166648
[TBL] [Abstract][Full Text] [Related]
19. The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues.
Kudithipudi S; Dhayalan A; Kebede AF; Jeltsch A
Biochimie; 2012 Nov; 94(11):2212-8. PubMed ID: 22583696
[TBL] [Abstract][Full Text] [Related]
20. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription.
Beck DB; Oda H; Shen SS; Reinberg D
Genes Dev; 2012 Feb; 26(4):325-37. PubMed ID: 22345514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
